AUXILIUM PHARMACEUTICALS, INC. – Trademark Portfolio
Entity Type: 03
AUXILIUM PHARMACEUTICALS, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TESTIM and TESTIM 1% (TESTOSTERONE GEL) III. The owner is based in Malvern, PA.
1400 Atwater Drive
Malvern, PA 19355
Showing of trademarks Trademarks
Trademark Classifications
AUXILIUM PHARMACEUTICALS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does AUXILIUM PHARMACEUTICALS, INC. have?
AUXILIUM PHARMACEUTICALS, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 2 cancelled.
What trademark classes does AUXILIUM PHARMACEUTICALS, INC. file in?
AUXILIUM PHARMACEUTICALS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 16 (Paper Goods), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are AUXILIUM PHARMACEUTICALS, INC.'s most well-known trademarks?
AUXILIUM PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as TESTIM and TESTIM 1% (TESTOSTERONE GEL) III. These are among 2 currently registered trademarks in the portfolio.
What is AUXILIUM PHARMACEUTICALS, INC.'s trademark registration success rate?
AUXILIUM PHARMACEUTICALS, INC. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.